For presenting your thesis proposal, today on December 1st at Johns Hopkins University School of Public Health.
This week, ERGOT Faculty Dr. Tanjala Purnell-Idowu and Bloomberg Distinguished Professor Dr. Lisa Angeline Cooper launched a new course in the Johns Hopkins Bloomberg School of Public Health, “Applications of Innovative Methods in Health Equity Research.” The course involved an amazing team of faculty members, including ERGOT Faculty Dr. Macey Henderson and several faculty members from the Johns Hopkins Center for Health Equity. Students (from all over the world) were very enthusiastic and actively engaged in the course and learned about novel methods, practical tools, and skills required to conduct health equity research and to translate evidence-based strategies into practice and policy.
We are proud to support Dr. Purnell and her ongoing work addressing health equity.
We were excited for the opportunity to present our work at the first ever Hopkins Surgery Research Day (May 24, 2017)! We brought 12 posters and gave 2 talks.
Congrats to our Research Data Analyst Mary Grace Bowring for her award winning poster on Sex and Size Disparity in Liver Transplant!
Core Faculty member and 2015 Rothman Early Career Development Award for Surgical Science award winner Dr. Tanjala Purnell gave an update on her ongoing research titled, “Patient Centered Research to Improve Equity in Access to Kidney Transplantation.”
Another highlight was our Halsted resident and PhD candidate Dr. Sandra DiBrito sharing her research in general surgery and transplantation, titled, “Outcomes Following General Surgery in Kidney Transplant Recipients.”
Thank you to the Johns Hopkins Department of Surgery for facilitating a great day of sharing engaging surgical science!
Completing the trilogy of papers published in the December issue of the American Journal of Transplantation that was dedicated to living donors, our lab looks for Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.
We looked at studies averaging less than 10 years of follow-up to better understand postdonation ESRD.
Drs. Niraj Desai and Christine Durand talk with CBS Baltimore about transplanting patients with hepatitis C-infected kidneys. The Johns Hopkins trial includes 10 patients from Baltimore, 5 of which have already been transplanted.
This is now a viable option now the hepatitis C is curable. This has the potential to shrink the transplant waitlist which is currently over 200,000 people in the US, 82-percent of whom need kidneys.
“If we had enough organs, we wouldn’t do this,” says Dr. Desai.